Malignant Breast Neoplasm

3

Review clinical trials related to Malignant Breast Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

This trial studies the safety and how well negative pressure wound therapy works in healing the abdominal incision in obese patients undergoing free flap breast reconstruction surgery. Using negative pressure wound therapy (NPWT) instead of standard dressing (bandages) may improve wound healing at the surgical site in the abdomen where tissue was collected for breast reconstruction surgery.

Participants needed: 80
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Apr 21, 2026Locations: 1
Eligibility criteria

Patients undergoing a free abdominal flap, including a superficial inferior epig... [+2]

Patients who are unable to provide consent. [+2]

Status: Recruiting

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

This is a single institution phase II randomized study evaluating the potential benefits of a supplement, tart cherry juice at high- versus low-doses, to prevent taxane induced peripheral neuropathy in breast and ovarian cancer patients undergoing paclitaxel chemotherapy. Eligible participants enrolled onto the study will be block randomized in a 1:1 allocation to either the tart cherry juice high-dose group (Arm 1) or the tart cherry juice low-dose group (Arm 2).

Participants needed: 86
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University of California, DavisUpdated: Mar 4, 2026Locations: 1
Eligibility criteria

Histologically confirmed invasive breast or ovarian cancer (Stage I, II, III, or... [+17]

Have received any prior therapy with taxanes, vinca alkaloids, eribulin, ixabepi... [+9]

Status: Recruiting

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

The reduction in the number of fractions in radiotherapy is especially attractive in several senses, and even more so considering breast cancer, which has a high incidence and generally favorable prognosis. Thus, as a reference Institution, the investigators intend to start the treatment of selected patients with a radiotherapy scheme of 26 Gy / 5 fractions in one week, in a controlled manner, through this project.The investigators consider the moment extremely propitious to start the study, as in addition to having the first publication of a large randomized study, proving the effectiveness and safety of the strategy, the investigators will be able to benefit more patients and the health system itself by minimizing the daily visits of these patients at the hospital.

Participants needed: 36
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Instituto Brasileiro de Controle do CancerUpdated: Dec 29, 2022Locations: 1
Eligibility criteria

Information to the patient and signed informed consent; [+9]

Previous local irradiation; [+6]